Brief: Iconovo Sets Financial Targets For 2026

Iconovo AB

21/05/2021 07:15

May 21 (Reuters) - Iconovo AB  ICO.ST :
    * ICONOVO SETS AMBITIOUS FINANCIAL TARGETS FOR 2026
    * ICONOVO AB - BY 2026, COMPANY EXPECTS TO ACHIEVE SALES OF SEK 200 MILLION
    * ICONOVO AB - TARGET FOR OPERATING PROFIT IS SEK 100 MILLION, CORRESPONDING TO AN OPERATING
MARGIN OF 50%
    * ICONOVO AB - TARGET FOR OPERATING MARGIN IN 2026 IS TO ACHIEVE 50% AND THEREBY AN
OPERATING
PROFIT OF SEK 100 MILLION
    * ICONOVO AB - ICONOVO EXPECTS TO HAVE ABOUT 50 EMPLOYEES IN FIVE YEARS WITH TEN PROJECTS IN
DEVELOPMENT AND FIVE LAUNCHED INHALATION PROJECTS THAT GENERATE ROYALTIES
    * ICONOVO AB - EXPECTS TO ACHIEVE A TURNOVER OF SEK 200 MILLION BY 2026
    * ICONOVO AB - APPROXIMATELY 1/3 OF TURNOVER IS ESTIMATED TO COME FROM ICONOVO'S
PHARMACEUTICAL
SALES IN NORDICS THROUGH ICONOVO PHARMA.
    * ICONOVO AB - TARGET FOR OPERATING MARGIN IN 2026 IS TO ACHIEVE 50% AND THEREBY AN
OPERATING
PROFIT OF SEK 100 MILLION
    * ICONOVO AB - ESTIMATES THAT ROYALTY REVENUES FROM GENERIC INHALATION PRODUCTS WILL ACCOUNT
FOR
2/3 OF SALES IN 2026
    * ICONOVO AB - ICONOVO CHOOSES TO SEE US AS AN UPSIDE THAT COULD REACH A REVENUE OF SEK 70
MILLION
IN 2026

Source text for Eikon:  ID:nMFNdq4tj 
Further company coverage:  ICO.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))